Propofol postconditioning alleviates diabetic myocardial ischemia‑reperfusion injury <em>via</em> the miR‑200c‑3p/AdipoR2/STAT3 signaling pathway

Huang,Lijun; Ding,Li; Yu,Shenghui; Huang,Xin; Ren,Qiusheng

doi:10.3892/mmr.2022.12653

Propofol postconditioning alleviates diabetic myocardial ischemia‑reperfusion injury via the miR‑200c‑3p/AdipoR2/STAT3 signaling pathway

Authors:
- Lijun Huang
- Li Ding
- Shenghui Yu
- Xin Huang
- Qiusheng Ren
View Affiliations

Affiliations: Department of Anesthesiology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang 315040, P.R. China
Published online on: February 22, 2022 https://doi.org/10.3892/mmr.2022.12653
Article Number: 137
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Myocardial ischemia/reperfusion (MI/RI) syndrome is one of the leading causes of mortality and disability. Propofol postconditioning is known to improve myocardial ischemia/reperfusion injury (MI/RI). The present study aimed to explore the mechanism of propofol postconditioning in diabetic MI/RI. Diabetic MI/RI rat models were established and the rats were treated via propofol postconditioning. Staining with 2,3,5‑triphenyl‑2H‑tetrazolium chloride, H&E staining, TUNEL staining and ELISA were applied to detect infarct size, pathological changes, apoptosis and oxidative stress‑related factor and apoptotic factor levels, respectively. Subsequently, the effect of propofol on H9C2 cells was also assessed using the Cell Counting Kit‑8 assay. High‑glucose hypoxia/reperfusion (H/R) models of H9C2 cardiomyocytes were established. miR‑200c‑3p overexpression or AdipoR2 silencing combined with propofol postconditioning was performed in H/R‑induced H9C2 cells and STAT3 protein expression levels were determined. Propofol postconditioning significantly reduced myocardial infarct size, oxidative stress and apoptosis in diabetic MI/RI models. Furthermore, propofol postconditioning significantly reduced the oxidative stress and apoptosis of H9C2 cells in high‑glucose H/R models. Propofol postconditioning also significantly downregulated miR‑200c‑3p expression levels and promoted AdipoR2 expression levels. miR‑200c‑3p overexpression or AdipoR2 downregulation significantly reversed the effects of propofol postconditioning on its antioxidation and anti‑apoptotic effects in H9C2 cells and on decreasing STAT3 phosphorylation levels. Together, the results of the present study demonstrated that propofol postconditioning inhibited miR‑200c‑3p, upregulated AdipoR2 and activated the STAT3 signaling pathway, thus alleviating diabetic MI/RI and therefore highlighting its potential as a treatment of diabetic MI/RI.

View Figures

View References

1	Kerner W and Bruckel J; German Diabetes Association, : Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 122:384–386. 2014. View Article : Google Scholar : PubMed/NCBI
2	Yu SY, Dong B, Fang ZF, Hu XQ, Tang L and Zhou SH: Knockdown of lncRNA AK139328 alleviates myocardial Ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy. J Cell Mol Med. 22:4886–4898. 2018. View Article : Google Scholar : PubMed/NCBI
3	Tao A, Xu X, Kvietys P, Kao R, Martin C and Rui T: Experimental diabetes mellitus exacerbates ischemia/reperfusion-induced myocardial injury by promoting mitochondrial fission: Role of down-regulation of myocardial Sirt1 and subsequent Akt/Drp1 interaction. Int J Biochem Cell Biol. 105:94–103. 2018. View Article : Google Scholar : PubMed/NCBI
4	Li J, Zhao Y, Zhou N, Li L and Li K: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress. J Diabetes Res. 2019:78693182019. View Article : Google Scholar : PubMed/NCBI
5	Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011. View Article : Google Scholar : PubMed/NCBI
6	Xu Y, Pan S, Jiang W, Xue F and Zhu X: Effects of propofol on the development of cancer in humans. Cell Prolif. 53:e128672020. View Article : Google Scholar : PubMed/NCBI
7	Yan HJ, Qi GQ and Ma Y: Effect of propofol on myocardial ischemia-reperfusion injury through MAPK/ERK pathway. Eur Rev Med Pharmacol Sci. 23:11051–11061. 2019.PubMed/NCBI
8	Facey J, Young L and Nwokocha C: Relaxation responses of ketamine and propofol to vasoactive agents in Streptozotocin-induced diabetic rats. Niger J Physiol Sci. 35:33–39. 2020.PubMed/NCBI
9	Deng F, Wang S, Zhang L, Xie X, Cai S, Li H, Xie GL, Miao HL, Yang C, Liu X and Xia Z: Propofol through upregulating Caveolin-3 attenuates Post-hypoxic mitochondrial damage and cell death in H9C2 cardiomyocytes during hyperglycemia. Cell Physiol Biochem. 44:279–292. 2017. View Article : Google Scholar : PubMed/NCBI
10	Lin C, Sui H, Gu J, Yang X, Deng L, Li W, Ding W, Li D and Yang Y: Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats. Microvasc Res. 90:162–168. 2013. View Article : Google Scholar : PubMed/NCBI
11	Hao W, Zhao ZH, Meng QT, Tie ME, Lei SQ and Xia ZY: Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Cell Biol Int. 41:495–504. 2017. View Article : Google Scholar : PubMed/NCBI
12	Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
13	Zhen W, Hui D, Wenying S and Yulong S: MicroRNA-20b-5p regulates propofol-preconditioning-induced inhibition of autophagy in hypoxia-and-reoxygenation-stimulated endothelial cells. J Biosci. 45:352020. View Article : Google Scholar : PubMed/NCBI
14	Dehaini H, Awada H, El-Yazbi A, Zouein FA, Issa K, Eid AA, Ibrahim M, Badran A, Baydoun E, Pintus G and Eid AH: MicroRNAs as potential pharmaco-targets in ischemia-reperfusion injury compounded by diabetes. Cells. 8:1522019. View Article : Google Scholar : PubMed/NCBI
15	Climent M, Viggiani G, Chen YW, Coulis G and Castaldi A: MicroRNA and ROS crosstalk in cardiac and pulmonary diseases. Int J Mol Sci. 21:43702020. View Article : Google Scholar : PubMed/NCBI
16	Zhao B, Gao WW, Liu YJ, Jiang M, Liu L, Yuan Q, Hou JB and Xia ZY: The role of glycogen synthase kinase 3 beta in brain injury induced by myocardial ischemia/reperfusion injury in a rat model of diabetes mellitus. Neural Regen Res. 12:1632–1639. 2017. View Article : Google Scholar : PubMed/NCBI
17	Li H, Yao W, Liu Z, Xu A, Huang Y, Ma XL, Irwin MG and Xia Z: Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in diabetic rats. Diabetes. 65:942–955. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wang HY, Wang GL, Yu YH and Wang Y: The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res. 1297:177–184. 2009. View Article : Google Scholar : PubMed/NCBI
19	Zhu HJ, Wang DG, Yan J and Xu J: Up-regulation of microRNA-135a protects against myocardial ischemia/reperfusion injury by decreasing TXNIP expression in diabetic mice. Am J Transl Res. 7:2661–2671. 2015.PubMed/NCBI
20	Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Wang T, Mao X, Li H, Qiao S, Xu A, Wang J, Lei S, Liu Z, Ng KF, Wong GT, et al: N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med. 63:291–303. 2013. View Article : Google Scholar : PubMed/NCBI
23	Wang T, Qiao S, Lei S, Liu Y, Ng KF, Xu A, Lam KS, Irwin MG and Xia Z: N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One. 6:e239672011. View Article : Google Scholar : PubMed/NCBI
24	Zhan L, Zhang Y, Su W, Zhang Q, Chen R, Zhao B, Li W, Xue R, Xia Z and Lei S: The roles of autophagy in acute lung injury induced by myocardial ischemia reperfusion in diabetic rats. J Diabetes Res. 2018:50475262018. View Article : Google Scholar : PubMed/NCBI
25	Li YM, Sun JG, Hu LH, Ma XC, Zhou G and Huang XZ: Propofol-mediated cardioprotection dependent of microRNA-451/HMGB1 against myocardial ischemia-reperfusion injury. J Cell Physiol. 234:23289–23301. 2019. View Article : Google Scholar : PubMed/NCBI
26	Wang Y, Che J, Zhao H, Tang J and Shi G: Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury. Biochem Biophys Res Commun. 503:3219–3224. 2018. View Article : Google Scholar : PubMed/NCBI
27	Rahimi R, Karimi J, Khodadadi I, Tayebinia H, Kheiripour N, Hashemnia M and Goli F: Silymarin ameliorates expression of urotensin II (U-II) and its receptor (UTR) and attenuates toxic oxidative stress in the heart of rats with type 2 diabetes. Biomed Pharmacother. 101:244–250. 2018. View Article : Google Scholar : PubMed/NCBI
28	Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W and Tang Q: Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 9:690–701. 2019. View Article : Google Scholar : PubMed/NCBI
29	Chen Y and Li Z: Protective effects of propofol on rats with cerebral ischemia-reperfusion injury via the PI3K/Akt Pathway. J Mol Neurosci. 71:810–820. 2021. View Article : Google Scholar : PubMed/NCBI
30	Li H, Zhang X, Tan J, Sun L, Xu LH, Jiang YG, Lou JS, Shi XY and Mi WD: Propofol postconditioning protects H9c2 cells from hypoxia/reoxygenation injury by inducing autophagy via the SAPK/JNK pathway. Mol Med Rep. 17:4573–4580. 2018.PubMed/NCBI
31	Tang M, Liu P, Li X, Wang JW, Zhu XC and He FP: Protective action of B1R antagonist against cerebral ischemia-reperfusion injury through suppressing miR-200c expression of Microglia-derived microvesicles. Neurol Res. 39:612–620. 2017. View Article : Google Scholar : PubMed/NCBI
32	Wu Y, Gu C and Huang X: Sevoflurane protects against hepatic ischemia/reperfusion injury by modulating microRNA-200c regulation in mice. Biomed Pharmacother. 84:1126–1136. 2016. View Article : Google Scholar : PubMed/NCBI
33	Shi D, Guo L, Sun X, Shang M, Meng D, Zhou X, Liu X, Zhao Y and Li J: UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis. Sci Rep. 10:66572020. View Article : Google Scholar : PubMed/NCBI
34	Nunomura A and Perry G: RNA and oxidative stress in Alzheimer's disease: Focus on microRNAs. Oxid Med Cell Longev. 2020:26381302020. View Article : Google Scholar : PubMed/NCBI
35	Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, Li R, Gao EH, Koch WJ, Ma XL and Wang YJ: AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab. 309:E275–E282. 2015. View Article : Google Scholar : PubMed/NCBI
36	Li D, Song LL, Wang J, Meng C and Cui XG: Adiponectin protects against lung ischemia-reperfusion injury in rats with type 2 diabetes mellitus. Mol Med Rep. 17:7191–7201. 2018.PubMed/NCBI
37	Wang Y, Liang B, Lau WB, Du Y, Guo R, Yan Z, Gan L, Yan W, Zhao J, Gao E, et al: Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling. Autophagy. 13:1855–1869. 2017. View Article : Google Scholar : PubMed/NCBI
38	Zhang Y, Zheng LM, Wang CX, Gu JM and Xue S: SENP3 protects H9C2 cells from apoptosis triggered by H/R via STAT3 pathway. Eur Rev Med Pharmacol Sci. 22:2778–2786. 2018.PubMed/NCBI
39	Chen X, Wang Y, Xiao ZY, Hou DN, Li DB and Zhang XP: Effect of propofol on myocardial ischemia/reperfusion injury in rats through JAK/STAT signaling pathway. Eur Rev Med Pharmacol Sci. 23:6330–6338. 2019.PubMed/NCBI
40	Li K, Zhou P, Li S, Zheng S and Wang D: MicroRNA-29b reduces myocardial ischemia-reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathway. J Thromb Thrombolysis. 53:123–135. 2021. View Article : Google Scholar : PubMed/NCBI